Benzodiazepine receptor distribution in severe intractable tinnitus

International Tinnitus Journal

Volumn 10, Issue 1, 2004, Pages 17-23

  Daftary, Aditya ^a,b   Shulman, Abraham ^c   Strashun, Arnold M ^b   Gottschalk, Christopher ^b   Zoghbi, Sami S ^e   Seibyl, John P ^a,b,d  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

^d Inst for Neurodeg Disorders   (United States)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Brain single photon emission computed tomography (SPECT); Gamma aminobutyric acid (GABA); Iomazenil; Receptor imaging; Statistical Parametric Mapping (SPM); Tinnitus

Indexed keywords

4 AMINOBUTYRIC ACID; BENZODIAZEPINE RECEPTOR; IOMAZENIL I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN REGION; CEREBELLUM; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HUMAN; MALE; NERVE FUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARD; TEMPORAL CORTEX; THALAMUS; TINNITUS; UNITED STATES;

ADULT; AGED; BRAIN; BRAIN MAPPING; CASE-CONTROL STUDIES; FEMALE; FLUMAZENIL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RECEPTORS, GABA-A; TINNITUS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 3142713716     PISSN: 09465448     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Shulman A. A final common pathway for tinnitus - the medial temporal lobe system. Int Tinnitus J 1(2):115-126, 1995.
2. Lechtenberg R, Shulman A. Benzodiazepines in the treatment of tinnitus. Arch Neurol 41:718-721, 1984.
3. Collins RC, Dobkin BH, Choi DW. Selective vulnerability of the brain: new insights into the pathophysiology of stroke. Ann Intern Med 110(12):992-1000, 1989.
4. Shulman A. Neuroprotective drug therapy: A medical and pharmacological treatment for tinnitus control. Int Tinnitus J 3(2):77-93, 1997.
5. Melding PS, Goodey RS, Thorne PR. The use of intravenous lidocaine in the diagnosis and treatment of tinnitus. J Laryngol Otol 92:115-121, 1978.
6. Fujita M, et al. Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans. Eur J Pharmacol 368(2-3):161-172, 1999.
7. Abi-Dargham A, et al. No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia. Neuropsychopharmacology 20(6):650-661, 1999.
8. 123I] Iomazenil. Am J Psychiatry 155(11): 1550-1555, 1998.
9. Bremner JD, et al. Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am J Psychiatry 157(7):1120-1126, 2000.
10. Verhoeff NP, et al. [123-I] Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia. Psychiatry Res 91(3):163-173, 1999.
11. 123I] Iomazenil: Preliminary results of a direct comparison in healthy human subjects. Psychiatry Res 91(2):79-91, 1999.
12. Shulman A, et al. Tinnitus Diagnosis/Treatment. Philadelphia: Lea & Febiger, 1991.
13. 123I] Iomazenil by iododestannylation: Implications for the reaction mechanism. Appl Radiat Isot 45(1):63-68, 1994.
14. 123I] Iomazenil in human and non-human primates. Nucl Med Biol 19(8):881-888, 1992.
15. Abi-Dargham A, et al. SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: Kinetic and equilibrium paradigms. J Nucl Med 35(2):228-238, 1994.
16. Gandelman MS, et al. Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil. J Pharm Sci 83(7):1014-1019, 1994.
17. Chang LA. Method for attenuation correction in computed tomography. IEEE Trans Nucl Sci 25:638-643, 1987.
18. Friston KJ, et al. Statistical parametric maps in functional imaging: A general linear approach. Hum Brain Map 2:189-210, 1995.
19. Shulman A, et al. SPECT imaging of brain and tinnitus-neurotologic/ neurologic implications. Int Tinnitus J 1(1): 13-29, 1995.
20. Mirz F, et al. Positron emission tomography of cortical centers of tinnitus. Hear Res 134(1-2):133-144, 1999.
21. Giraud AL, et al. A selective imaging of tinnitus. Neuroreport 10(1):1-5, 1999.
22. Arnold W, et al. Focal metabolic activation in the predominant left auditory cortex in patients suffering from tinnitus a PET study with [18F] deoxyglucose. J Otorhinolaryngol 58(4):195-199, 1996.
23. Shulman A, Goldstein B. A final common pathway for tinnitus-implications for treatment. Int Tinnitus J 2:137-142, 1996.
24. Shulman A, Goldstein B. Medical significance of tinnitus. Int Tinnitus J 3(1):45-50, 1997.
25. Shulman A, et al. Benzodiazepine receptor deficiency and tinnitus. Int Tinnitus J 6(2):98-111, 2000.
26. 11C] Ro 15-4513. Neurosci Lett 159(1-2):207-210, 1993.
27. 123I] Iomazenil SPECT imaging demonstrates significant benzodiazepine receptor reserve in human and nonhuman primate brain. Neuropharmacology 32(7):671-680, 1993.